
    
      Patients will be stratified at randomization according to first-line chemotherapy /
      Second-line chemotherapy for metastatic or locally recurrent breast cancer

      Treatment until progression or unacceptable toxicity Visits are planned every 3 weeks during
      treatment and every 3 months after end of treatment or patient's withdrawal
    
  